Infection of inbred mouse strains with Citrobacter rodentium represents an ideal model to reveal the genetic factors controlling host resistance to noninvasive enteric bacterial pathogens. We have chosen a positional cloning approach to identify putative gene(s) that control the known difference in survival between resistant C57BL/6J and susceptible C3H/HeJ and C3H/HeOuJ mice. Our work has identified one major locus within proximal chromosome 15 that is responsible for the marked susceptibility of both C3H strains, and we formally exclude Tlr4 from control of survival to this pathogen. We have named this new host resistance locus Cri1 (Citrobacter rodentium infection 1). The Cri1 genetic interval currently spans B16 Mb and it confers survival to the infection in a recessive manner. Transfer of the Cri1 locus from the surviving B6 mice into a congenic mouse with a C3Ou genetic background confirms its overall chromosomal localization and its highly significant effect on host survival. The C3Ou.B6-Cri1 mice thus produced have also enabled us to dissociate the control of mouse survival from the control of bacterial load early in the infection as well as from control of colonic hyperplasia.
Introduction
Citrobacter rodentium infection of mice was first described in the 1960s and 1970s as the suspected causative agent of outbreaks of diarrhea, colitis and colonic hyperplasia in mouse colonies in the United States and Japan. [1] [2] [3] [4] [5] More recently, infection of mice with this intestinal pathogen has become recognized as an excellent model for infection with the human-specific diarrheal pathogens enterohemorrhagic and enteropathogenic Escherichia coli (EHEC and EPEC; reviewed in Mundy et al. 6 ). EPEC kills several hundred thousand children each year in developing countries, 7 whereas EHEC is commonly associated with foodborne diarrheal outbreaks in the developed world. 8 Over 110 000 cases of EHEC infection and 61 EHEC-associated deaths are estimated to occur each year in the United States alone. 9 Furthermore, recent epidemiological data indicate that both the frequency of EHEC outbreaks and the severity of disease suffered are on the increase. 10 These observations are all the more worrisome as there are currently no specific therapeutic regimens for EHEC infections; antibiotic use is not recommended as it exacerbates disease and increases the rate of development of complications.
The parallels between C. rodentium infection of mice and EHEC and EPEC infection of humans are striking. These Enterobacteriaceae colonize the gastrointestinal tract of their hosts by the formation of characteristic attaching/effacing lesions, leading to the development of diarrhea, colitis and hyperplasia of the intestinal epithelium. Using a type III secretion system that is conserved between all three bacterial species, they inject bacterial virulence proteins directly into host cells. Recent genomic and proteomic characterization of the secreted protein repertoires in EHEC, EPEC and C. rodentium indicates that the vast majority of injected virulence proteins are common to all three bacterial species. 12, 13 Consequently, it is not surprising that the C. rodentium model is now widely used to investigate the role of bacterial virulence proteins and host defense mechanisms in the attaching/effacing pathogenesis.
Studies in humans indicate that the disease severity and clinical outcome of EHEC and EPEC infection can vary greatly between individuals. [14] [15] [16] [17] Whether these differences have a genetic basis is undetermined. On the other hand, differences in susceptibility to C. rodentium infection in mice were first described in 1977, when an abnormally high mortality rate was noted in the C3H/HeJ strain. 18 Later studies revealed that C3H/HeJ mice are highly susceptible to Salmonella infection and are hyporesponsive to bacterial lipopolysaccharide because of a mutation in Toll-like receptor 4 (Tlr4), raising the question of whether the Tlr4 defect was also responsible for C. rodentium susceptibility. However, the finding that the closely related but Tlr4-wild-type mouse strain C3H/HeOuJ is also susceptible to C. rodentium infection suggested that C. rodentium susceptibility was independent of Tlr4. 19 Additional support for this was provided by side-by-side phenotypic studies of Tlr4-deficient and Tlr4-wild-type mice. 20 In this study we apply a systematic genetic approach to the C. rodentium infection model to investigate the genetic basis for high mortality in C3H/HeJ and C3H/HeOuJ mice.
Results
Phenotypic differences between C57BL/6J and C3H inbred mice during C. rodentium infection The inbred mouse strains C3H and C57BL/6J (B6) differ in their susceptibility to C. rodentium infection. 18, 19 The most striking difference being that mice of the C3H/HeJ (C3) and C3H/HeOuJ (C3Ou) strains succumb to the infection within 12 days following orogastric infection, whereas B6 mice not only survive but fully recover and clear the infection (cumulative survival curves, Figure 1a ). Besides the obvious difference in survival between the B6 and both C3H strains, the C3Ou strain displays a reproducible and statistically significant increase in survival time when compared with the C3 strain (Po0.0001 with a log-rank statistical test). Compared with B6 mice, C3 and C3Ou mice also display a much more rapid rate of colonization of the colon by C. rodentium, leading to significantly greater bacterial loads early on in infection. 19 Figure 1b shows a time course of C. rodentium shedding in the surviving B6 mouse strain and in the susceptible C3 and C3Ou strains. Two important observations can be made from the data obtained. First, the colony-forming unit (CFU) counts increase significantly faster in both C3H strains compared with B6 mice (Po0.05 at days 3-5 post infection), and that is consistent with previously published data. 19 Second, B6 mice reach similar high levels of C. rodentium shedding in fecal pellets before they start clearing the infection after day 10 post infection. Although it has been hypothesized that the greater bacterial loads early in infection may lead to mortality in C3H strains, 19 the link between these two phenotypic differences remains an open question.
In order to gain more insight into the phenotypes under study, the parental mouse strains were examined in detail at day 7 post infection. This is the time point closest to the peak of infection in C57BL/6J mice where there are still some surviving C3 mice (Figure 1a) . Mice from each of the infected inbred strains were killed and their cecum and colon dissected. At a macroscopic level (representative photographs in Supplementary Figure 1) , tissues from both C3H mouse strains display obvious symptoms of disease: the cecums are highly retracted and the colons are devoid of properly formed fecal pellets. Colonic hyperplasia and hemorrhage are evident as well, even at the macroscopic level. In contrast, B6 tissues display low levels of hyperplasia and only slightly increased water content in their fecal pellets. Although B6 mice are undeniably sick at that point, it is nowhere near the phenotype observed in C3H mice. We hypothesized that the observed phenotypic differences between the mouse strains may be controlled by discrete host genetic factors. In order to gain insight into the factors controlling these phenotypic differences, and to investigate the links between them, we set out to identify the genetic loci controlling the survival phenotype of B6 CFUs of C. rodentium. A total of 10 animals from each strain (5 males and 5 females) were infected. No significant differences in survival were noted between the sexes. Besides the obvious difference in survival between the C57BL/6J and both C3H strains, the C3Ou strain displays a reproducible and statistically significant increase in survival time when compared with the C3 strain (Po0.0001 logrank statistics). (b) Bacterial shedding in fecal pellets from infected inbred mice. Bacterial shedding is measured as C. rodentium CFU g -1 of homogenized fecal matter. Five mice from each inbred strain were infected and transferred into bedding-free isolation cages at the specified time points to collect six fresh fecal pellets from each. Bacterial shedding was measured every 24 h after infection. Data collection was stopped for the C3H strains at day 7, when signs of morbidity/mortality appeared. For the B6 mice, CFU counts were further compiled at days 10, 14 and 21 post infection to show bacterial clearance, as described previously. 33 Mean log-transformed bacterial counts are shown in the graph and error bars depict s.d. Nonlinear curve fitting was performed using fourth-order polynomial functions.
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Segregation of survival phenotype in F2 crosses
We undertook a systematic positional cloning effort by crossing the resistant B6 mice with either of the susceptible C3 and C3Ou strains and correlating inheritance patterns throughout the genome with the resulting survival phenotypes. Data analysis for the crosses to each of the two C3H mouse strains was kept separate throughout this study for two reasons: first, we have shown a small but significant difference in survival time between the C3Ou and C3 strains, and second, the C3 strain is known to carry a nonfunctional allele of the Tlr4 locus. 21, 22 Tlr4-mediated responses have previously been implicated in the onset of tissue pathology and morbidity in the context of C. rodentium infection. 20 Separate analyses would enhance our ability to distinguish common as well as distinct genetic factors controlling survival to C. rodentium infection in the C3Ou and C3 mouse strains.
F1 hybrid mice were obtained by crossing resistant B6 and susceptible C3 mice. These F1 mice were infected and survival was recorded: the cumulative survival curve obtained was intermediate relative to that of the parental strains, with 55% survival at day 30 post infection ( Figure 2a ). Very little mortality occurs beyond day 20 post infection throughout our studies. We are therefore comfortable with considering that mice that survived to day 30 are on the way to clearing the infection and are indeed 'survivors'. A total of 168 progeny from a (C3 Â B6)F2 cross (hereafter named C3B6F2) were similarly infected and survival was recorded. The F2 population appears to segregate roughly into two groups: 40% of the F2 mice are as resistant as the B6 parent and survive the infection, whereas the rest of the F2 mice succumb following infection, but display a significantly spread and delayed time of death compared with their C3 parents. 8 CFUs of C. rodentium. (a) (C3H/HeJxC57BL/6J)F2 cross. In all, 168 F2 animals were infected and survival was recorded. The F1 mice behaved as intermediates between the resistant C57BL/6J and the susceptible C3H/HeJ parents, with roughly 50% survival by day 30 post infection. The F2 population appears to segregate more or less into two groups. Approximately 50% of the F2 mice are as resistant as the B6 parent and survive the infection, whereas the rest of the F2 mice succumb following infection but display a significantly delayed and spread time of death compared with their C3 parents. (b) (C3H/HeOuJ Â C57BL/6J)F2 cross. In all, 199 F2 animals were infected and survival was recorded. The F1 mice displayed an intermediate but fairly resistant phenotype, with an 80% survival rate by day 30 post infection. The F2 mice showed a continuous distribution in survival very comparable with the one displayed by the C3 F2 cross except slightly shifted toward a more resistant phenotype. (c) Examination of the frequency distribution of the survival in the (C3 Â B6)F2 mice reveals that the phenotype is not normally distributed and presents a major spike in the distribution at day 30 (censored data, shown with crosshatched pattern). Also, when considering only nonsurviving mice (noncensored data), the phenotype is not normally distributed as there is a sharp increase in mortality early in infection (days [10] [11] [12] [13] [14] and then a gradual decrease in mortality up to days 24-27, leading to a distribution with a long 'tail' toward the right-hand side of the graph. (d) Examination of the frequency distribution of the survival in the (C3Ou Â B6)F2 mice reveals an even larger spike in the distribution at day 30 (censored data). For the nonsurviving mice, the phenotype is not normally distributed, as seen for the C3-derived mice.
Cri1 and susceptibility to C. rodentium infection E Diez et al population. However, the C3OuB6F2 cumulative survival curve was slightly shifted toward a more resistant phenotype (58% survival at day 30) than that of C3B6F2 mice. An examination of the frequency distribution for the survival time of C3B6F2 mice ( Figure 2c ) reveals that the phenotype is not normally distributed. There is a major spike in the distribution profile at day 30 representing surviving mice (censored data, shown with crosshatched pattern). The survival time distribution for C3OuB6F2 mice reveals an even larger spike of surviving mice at day 30 ( Figure 2d ). When considering only nonsurviving mice (noncensored data), the phenotype is not normally distributed either: there is a sharp increase in mortality early in infection (days [10] [11] [12] [13] [14] and then a gradual decrease in mortality up to days 24-27, leading to a distribution with a long 'tail' toward the right-hand side of the graph. This is seen in both crosses, although it is more evident in the C3 cross (Figures 2c and d) . Importantly, no sex-dependent differences were observed among the parental inbred strains or among cross progeny (data not shown). All analyses shown in this study are therefore the result of pooling male and female data.
Localization of loci controlling the survival phenotype
The 168 C3B6F2 and the 199 C3OuB6F2 mice were each genotyped for polymorphic markers covering their entire genome. These markers were all chosen for their ability to discriminate between B6 and C3H chromosomal segments being inherited by the F2 hybrids at each locus. Supplementary Table 1 shows the names and positions of the markers used. The genetic maps derived from the crosses in this study are shown in Supplementary Figure 2 . Given the nature and distributions of the phenotypes under study, a parametric survival regression on the markers, under the Cox proportional hazards model, was chosen for the genome scan and performed with the statistical program R (http://www.R-project. org). The P ¼ 0.05 genome-wide significance threshold for the LOD (logarithm (base 10) of odds) scores, obtained by interpolation of the P-values computed using 100 000 bootstrapped samples, was 3.57 for the (C3 Â B6)F2 cross and 3.28 for the (C3Ou Â B6)F2 cross. One single locus was found to be associated with survival in the (C3 Â B6)F2 cross ( Figure 3a ): a highly significant LOD score of 13.42 (Po10
À5
) was detected at position 13.58 cM on proximal chromosome 15 (chr15). The horizontal dashed lines represent the genome-wide significance threshold using 100 000 bootstrapped samples (P ¼ 0.05). One significant association is found for the (C3 Â B6)F2 cross (Cri1 on mChr15) and two significant associations are detected for the (C3Ou Â B6)F2 cross (Cri1 on mChr15 and Cri2 on mChr5).
Cri1 and susceptibility to C. rodentium infection E Diez et al This locus will be referred to as Cri1 (Citrobacter rodentium infection 1). The statistics in Table 1 define a genetic interval of significant association with survival with LOD score peak at marker 15-033125499-M (rs3720676), which is physically located at chr15: 32 963 563 bp according to build 37 of the mouse genome assembly. The 1.5-LOD support interval for this peak spans 28.1 Mb, from marker 15-020953071-M (rs3714893) to marker 15-049283927-M (rs3719583).
The (C3Ou Â B6)F2 cross ( Figure 3b ) yielded two loci that are significantly associated with the survival phenotype. A highly significant LOD score of 12.56 (Po10 À5 ) was detected at position 12.63 cM on chr15. That peak overlaps almost perfectly with the Cri1 locus found in the C3 cross as can be seen in Table 1 . The peak of the genetic interval with significant association with survival occurs at marker 15-039906196-M (rs3683812), which is physically located at chr15: 39 561 915 bp according to build 37. This peak has a 1.5-LOD support interval spanning 15.9 Mb, from marker 15-033125499-M (rs3720676) to marker 15-049283927-M (rs3719583).
In the (C3Ou Â B6) F2 cross only, a second significant peak was detected in the middle of chromosome 5, at position 50.69 cM with the LOD score of 3.49 (P ¼ 0.03; Cri2). That peak corresponds to marker 5-116192311-M (rs3661429) and there is no flanking marker with the LOD score above the 3.3 genome-wide significance threshold defined above. No such peak can be observed in the (C3 Â B6)F2 cross.
Phenotypic effect of the Cri1 and Cri2 loci A cumulative survival curve is shown in Figure 4a , with the C3B6F2 mice grouped according to their genotype at the peak marker for the Cri1 locus. Most mice that inherited two B6-derived copies of the Cri1 locus survived the infection (94% survival at day 30 post infection), whereas mice that inherited two C3-derived copies of the Cri1 locus displayed a 20% survival rate. Mice with a heterozygous genotype at Cri1 displayed a cumulative survival curve that was not significantly different from that of homozygous C3 mice, with a final survival rate of 28%. The same analysis is shown for the (C3Ou Â B6)F2 cross in Figure 4b . In that cross, 96% of the mice that inherited both Cri1 alleles from the B6 parent survived, whereas only 30% of the F2 progeny with a homozygous C3Ou allele at Cri1 survived. In contrast with the C3B6F2 mice, however, heterozygotes (53% survival) were significantly more resistant than homozygous C3Ou littermates (P ¼ 0.02). Both of these graphs show clearly that C3H-derived Cri1 alleles confer susceptibility to C. rodentium infection in terms of survival. However, whereas the C3H allele is clearly dominant in the context of the C3 cross, it appears co-dominant or additive in the C3Ou cross. Once again, it appears that C3Ou mice produce progeny that are consistently more resistant to infection than those from the C3 strain.
C3OuB6F2 mice were also stratified according to their genotype at the Cri2 locus on chromosome 5 (Figure 4c ). The animals that inherited both copies of marker 5-116192311-M from their B6 parent displayed a 35% cumulative survival rate at day 30 post infection that is significantly lower (P ¼ 0.008) than littermates that inherited one or two copies from their C3Ou parent (68 and 61% survival, respectively). Thus, the C3Ou allele of the Cri2 locus confers a modest level of resistance to C. rodentium infection and is dominant over the B6 allele.
Tlr4 does not control the survival phenotype under study C3B6F2 mice used in this study effectively segregate the Tlr4 deficiency of C3H/HeJ inbred mice. This enabled us to clearly assess whether Tlr4 has any effect on mouse survival to C. rodentium infection. The genome scan shown in Figure 3a clearly fails to detect any significant linkage between mouse chromosome 4, where the Tlr4 gene is located, and the survival phenotype under study. To confirm that Tlr4 does not impact survival in our C3B6F2 cross, we analyzed the survival of all 168 mice in this cross according to their genotype at the Tlr4 gene Cri1 and susceptibility to C. rodentium infection E Diez et al ( Figure 5 ). All three resulting survival curves were completely superimposable, thus clearly dismissing any implication of the Tlr4 gene in the control of survival to C. rodentium infections. To determine if the strong effect of Cri1 was masking a minor effect of Tlr4 on survival, the same 168 C3B6F2 mice were analyzed for survival according to their genotype at Tlr4, but were also stratified according to their genotype at Cri1
(Supplementary Figure 3) . No significant effect of Tlr4 genotype on survival was seen, even in these stratified data. As discussed above, the Cri1 genotype of these mice was the major determinant of survival.
Transfer of the resistance allele of Cri1 via congenic mice In order to study the effect of Cri1 in the absence of other genetic differences between the parental strains, we generated a congenic mouse strain that we named C3Ou.B6-Cri1. This congenic strain carries a proximal 60 Mb segment of B6 chr15 encompassing the Cri1 locus introgressed in the genetic background of the C3Ou strain after at least nine backcross generations. Genotypic analysis of the congenic segment determined that it contains marker WI-WGS-15-4921676 (rs3698904; 0.5 Mb) at the proximal side. As this marker is close to the telomere, it is likely that the congenic segment extends to the telomere on the proximal side. On the distal side, marker (rs3702158; 57 Mb) is included and marker 15-063090495-M (rs3656705; 62 Mb) is excluded from the congenic segment. Therefore, the congenic segment in these mice comprises at least 57 Mb and o62 Mb of proximal chr15 from B6 mice introgressed onto the C3Ou background. C. rodentium infection of the congenic strain followed by survival analysis was conducted. We found that the congenic strain thus created survived the infection (96% cumulative survival). Effective transfer of the survival phenotype of the B6 inbred strain onto the otherwise susceptible C3Ou strain indicates that the genetic factor mediating the Cri1 effect is contained in the congenic region under study ( Figure 6 ). Moreover, heterozygote congenic littermates tested in parallel enabled us to show a complete dominance of the C3Ou susceptibility allele of Cri1 (0% cumulative survival at day 30 post infection). These heterozygous mice were not significantly different from noncongenic littermates and served as controls for the efficiency of the infection experiments. Thus, Cri1 controls survival following C. rodentium infection, and susceptibility is the dominant trait. Figure 5 Cumulative survival following C. rodentium infection in (C3 Â B6)F2 mice according to their genotype at Tlr4. Mice were grouped according to their genotype at genetic marker rs3023006 that represents the H712P amino-acid substitution in the Tlr4 protein of C3H/HeJ inbred mice responsible for their lipopolysaccharide (LPS)-unresponsive phenotype. 'B' represents mice homozygous for the B6 allele. 'C' represents mice homozygous for the C3H allele. 'H' represents mice heterozygous at the typed marker.
Cri1 and susceptibility to C. rodentium infection E Diez et al Cri1 does not control C. rodentium proliferation in the colon The experiments described above clearly show that the Cri1 locus controls mortality following C. rodentium infection. There are, however, a number of different phenotypes that can be studied during the infection and that distinguish the C3H from the B6 mouse inbred strains, some of which have been shown in Figure 1 .
The congenic mice we created provide the ideal tool to determine if the other phenotypic differences described between the parental strains are correlated with their increased mortality or not. One such phenotype is the C. rodentium colonization of the intestinal tract of the host (days 1-10 post infection).
In order to test if the C. rodentium colonization difference between the B6 and C3Ou mouse strains is controlled by the Cri1 locus, we measured both bacterial shedding in fecal pellets (Figure 7a ) and colonic CFU counts (Figure 7b ) in C3Ou.B6-Cri1 mice at day 5 post infection. In this study we provide further evidence that measuring bacterial shedding in fecal pellets (as was shown in Figure 1 as well) gives a good insight into the colonization of the colon by C. rodentium. Both types of measurements show that homozygous congenic mice displayed high CFU counts that were similar to the ones observed in control C3Ou mice and significantly higher Figure 7 Further phenotyping of Cri1-congenic mouse hosts during C. rodentium infection. (a) Bacterial shedding measured as C. rodentium CFU g -1 of homogenized fecal matter was measured at day 5 post infection. In all, eight homozygous congenics, four heterozygous congenics and six mice of each parental strain were used for this experiment. The bar graph depicts mean CFU counts with s.d. for each mouse strain. CFU counts obtained from both homozygous and heterozygous congenic mice were similar to those obtained from C3H controls tested in parallel and statistically different (higher) than those obtained from B6 controls (Po0.05 according to Dunn's post tests). (b) Bacterial colonization measured as C. rodentium CFUs per 1 cm sample of homogenized colon was measured at day 5 post infection. In all, 18 homozygous congenics, 8 heterozygous congenics and 12 mice of each parental strain were used for this experiment. The bar graph depicts mean CFU counts with s.d. for each mouse strain. CFU counts obtained from both homozygous and heterozygous congenic mice were similar to those obtained from C3H controls tested in parallel and statistically different (higher) than those obtained from B6 controls (Po0.01 according to Dunn's post tests). (c) Colon weights in mice at day 9 post infection with C. rodentium. Between three and six mice of each strain were used for this experiment. Uninfected mice or mice at day 9 post infection were killed and their entire colons from cecum to rectum were emptied of fecal pellets and weighed. The bar graph depicts mean weights with s.d. for each mouse strain/treatment. Colon weights obtained from infected congenic mice were similar to those obtained from C3Ou controls tested in parallel and statistically different (higher) than those obtained from infected B6 controls or uninfected colons from any of the strains (Po0.01 according to Tukey's post tests).
Cri1 and susceptibility to C. rodentium infection E Diez et al than the extremely low CFUs observed in B6 control mice infected in parallel (Po0.05 according to a Dunn's post test). Thus, the bacterial proliferation phenotype of the Cri1 congenic reflects the C3Ou background of the mice rather than the B6-derived segment encompassing the Cri1 locus. Indeed, when we performed a time course to compare the bacterial shedding of C3Ou and C3Ou.B6-Cri1 mice over the entire course of infection, no significant differences were seen between the two mouse strains up until and including the days that C3Ou mice succumbed to infection (days 1, 3, 5, 7 and 9; Supplementary Figure 4 ). By the day 14 time point, all C3Ou mice had succumbed to the infection. Notably, all C3Ou.B6-Cri1 congenic mice survived the infection despite displaying similar colonization kinetics and degree as C3Ou mice. Therefore, the increased early bacterial proliferation seen in C3H strains of mice is not controlled by Cri1 and is unrelated to their mortality after infection.
To determine the eventual outcome of infection in C3Ou.B6-Cri1 mice, we followed the fecal shedding of C. rodentium in C3Ou.B6-Cri1 mice beyond the time point at which C3Ou mice die and determined that C3Ou.B6-Cri1 mice progressively clear the infection (Supplementary Figure 4) . By day 29 of infection, there were no detectable C. rodentium in the colons of 3/6 C3Ou.B6-Cri1 mice and only low amounts (under 2.9 Â 10 3 CFU g -1 ) in the other three mice (data not shown), providing strong evidence that these mice clear the infection completely.
Cri1 does not control C. rodentium colonic hyperplasia As discussed above, the degree of colonic hyperplasia during infection is much greater in C3 and C3Ou mice than in B6 mice. In order to quantitate the extent of colonic hyperplasia during infection in the different mouse strains, and to determine whether this difference is controlled by Cri1, we determined the colon weights at day 9 post infection in B6, C3Ou and C3Ou.B6-Cri1 (Figure 7c ). As shown in the graph, the colon weights of C3Ou.B6-Cri1 mice were indistinguishable to those of C3Ou mice and significantly different from B6 mice, indicating that Cri1 does not control colonic hyperplasia following C. rodentium infection.
Discussion
We have applied a systematic approach to the identification of genetic factors responsible for the differential survival of B6 and C3H inbred mouse strains infected with the enteric pathogen C. rodentium. A genome scan using F2 crosses has yielded one major autosomal locus within proximal chr15 that we have named Cri1. This locus explains B25% of the phenotypic variance among the F2 mice studied. Our working hypothesis is that the Cri1 locus within chr15 is the main genetic determinant of survival to C. rodentium infection in both the C3H/HeJ and C3H/HeOuJ mouse strains. The C3Ou-specific Cri2 locus within chromosome 5 could potentially explain the small but significant difference in survival observed between the C3 and C3Ou C3H mouse strains. It is tempting to speculate that Cri2 may also be responsible for the apparent difference in the mode of inheritance of the Cri1 locus between C3B6F2 and C3OuB6F2 progeny. Indeed, when C3OuB6F2 mice are stratified according to their genotypes at both the Cri1 and Cri2 loci (Supplementary Figure 5 ), it becomes evident that mice that are heterozygous for Cri1 alleles can be either as susceptible as homozygotes for C3Ou-derived Cri1 alleles (35% survival at day 30 post infection), or of an intermediate phenotype (59% survival) depending on whether they inherited both Cri2 copies from their B6 parent or at least one C3Ou copy, respectively (significant effect of the Cri2 locus with P ¼ 0.02). Interestingly, C3OuB6F2 mice with homozygous alleles at Cri1 were unaffected by their Cri2 genotype. Our attempts to define locus interactions statistically were hampered by the relatively small sample size of the F2 crosses used. Given the very high LOD scores obtained at the Cri1 locus and the modest effect of any other loci, significantly larger sample sizes would be required to detect interactions reliably. Ultimately though, we decided to focus our efforts on confirming and isolating the effect of the Cri1 locus through the generation of congenic animals.
As opposed to the data acquired for the F2 cross, the congenic data that we have generated point to a complete dominance of the C3Ou-derived Cri1 allele in conferring susceptibility to C. rodentium infection. Together, these results suggest that there were factors being segregated in the F2 cross (other than Cri2) that have an impact on the survival phenotype and that have been eliminated with the congenic approach.
It has been previously suggested that it is the adaptive immune system, crypt cell apoptosis and bacterial translocation but not lipopolysaccharide responsiveness that may contribute to the tissue pathology and mortality seen during C. rodentium infection of highly susceptible mouse strains. 19 Our work has ascertained that the Tlr4 gene does not control survival to this Gram-negative extracellular bacterium.
Importantly, the Cri1 congenic mice generated in this study have not only confirmed the localization of the Cri1 locus to proximal chr15 but they have also enabled us to dissociate the survival phenotype controlled by the Cri1 locus from any control of C. rodentium proliferation or colonization of the host's distal colon. It has previously been suggested that these two phenotypes were related. 19 However, our Cri1 congenic data clearly show that mice can survive the infection even in the context of rapid bacterial replication. Thus, Cri1 controls survival of the host independently of the ability of the pathogen to colonize the gut in the early phase of the infection. We have extended our genetic screening of B6C3OuF2 mice to identify the loci that are responsible for the differential proliferation of C. rodentium in the colon of these two mouse strains and have thus far been unable to pinpoint the genetic loci responsible for a significant part of the phenotypic difference (data not shown). We are therefore tempted to suggest that it may be under complex genetic and perhaps environmental control.
The mortality of C3H inbred mice is a rather unique phenotype among mouse strains as there are many strains other than B6 that generally survive C .rodentium infections (129S1, A/J, BALB/c, CBA/J, DBA/2J, Ma/MyJ, SW; 19, 23, 24 in-house data not shown). There is, however, one more mouse strain that has been shown to display reduced survival during C. rodentium infection: the FvB/NTac strain. 23 FVB mice have been characterized with significant weight loss and mortality beginning
Cri1 and susceptibility to C. rodentium infection E Diez et al by 9 days post infection and B75% mortality by 21 days post infection. The mice develop epithelial cell hyperproliferation and severe inflammation with erosions and ulcers in the descending colon by 6 days post infection. Mortality can be fully prevented by fluid therapy, and genome-wide gene expression profiling of FVB mice compared with resistant SW mice has revealed an association between mortality and impaired intestinal ion transport and development of fatal fluid loss and dehydration. 25 Two ion transport genes were pinpointed because of their parallel expression profiles in the FVB and C3H mouse strains, namely a reduced expression by day 9 post infection, compared with uninfected mice as well as with infected B6 and SW resistant mice. The two genes identified in those studies were Slc26a3 (mouse chromosome 12) and CAIV (Car4) (mouse chromosome 11). Their findings suggested a common pathway (chloride ion absorption) associated with mouse mortality in both susceptible mouse strains. 26 However, our systematic approach to finding genetic loci that control the survival difference between B6 and C3H mice does not identify either of these two ion transporters as major causative agents. This finding, together with the fact that the downregulation of expression of these ion transport genes is only detectable by day 9 post infection, suggests that these expression differences might be the effects of lethal infection in the susceptible strains rather than causative factors. Our current study identifies Cri1 as a causative genetic agent for the mortality of C3H mice, but a proper genetic analysis of FVB mortality should be performed before a conclusion is reached about whether Cri1 controls survival of FVB mice as well. Notable phenotypic differences between the FVB and C3H strains as determined by Borenshtein et al. 26 included a significantly delayed mortality profile, slower body weight loss and lower bacterial shedding during the early stages of infection for FVB mice. The studies performed by these authors are crucial in that they show that fluid therapy effectively rescues the survival of C3H and FVB mice and therefore places dehydration caused by diarrhea as a probable cause of death. However, the mechanism by which mortality is prevented in resistant mouse strains may or may not be dependent on ion transport activities. Candidate genes under the 1.5-LOD support interval for the Cri1 locus do include ion transport genes: the ATP synthesis-coupled proton transporter Atp6v1c1 (38.6 Mb) and the two voltagegated potassium channel subunits Kcns2 (34.8 Mb) and Kcnv1 (44.9 Mb). However, the Cri1 candidate interval can also be considered to contain genes with a known function in the innate immune system such as the complement component 9 (C9; 6.4 Mb) or the scavenger receptor Enpp2 (54.7 Mb). It also overlaps the FYNbinding protein (Fyb; 6.5 Mb) for which deficient mice display reduced T-cell proliferation 27 as well as the interleukin 7 receptor (Il7r; 9.4 Mb), known to be an important regulator of B-and T-cell proliferation/ differentiation. 28 Although the Il7r gene seems relatively far proximal of the peak linkage region of the Cri1 locus, it is an intriguing candidate as B-cell function has been found to be essential for C. rodentium infection survival. 19, 29, 30 Ultimately, however, a continued systematic genetic approach may be required to identify the gene underlying the Cri1 locus. For that purpose, we are currently generating subcongenic mice that transfer smaller portions of the Cri1 locus from the B6 parental strain onto the C3Ou genetic background. Once a well-defined and smaller genomic candidate interval has been identified, we will undertake the screening of candidate genes for coding nonsynonymous mutations as well as for regulatory mutations. Functional validation of prioritized candidate genes in vivo will then be used to link candidate genes to the Cri1 survival phenotype.
Materials and methods

Animals used
All animal procedures were performed under conditions specified by the Canadian Council on Animal Care. C57BL/6J, C3H/HeJ and C3H/HeOuJ were purchased from the Jackson Laboratory (Bar Harbor, ME, USA). All animals were maintained in a specific pathogen-free facility at McGill University, and all experiments were approved by the animal care committee. (C57BL/ 6J Â C3H/HeJ) F1 and F2 and (C57BL/6J Â C3H/HeOuJ) F1 and F2 mice were generated at the McGill University Lyman Duff animal facility.
In vivo C. rodentium infections Mice were orally inoculated either with C. rodentium strain DBS100 wild type or that same strain rendered resistant to chloramphenicol (C m ) by the insertion of a mini-Tn7 transposon encoding chloramphenicol resistance into the glmS gene. The resulting antibiotic resistant strain was shown to be indistinguishable from the parental strain in terms of infectivity and kinetics during mouse infection. 31 For inoculations, bacteria were grown overnight in 3 ml Luria-Bertani broth shaking at 37 1C. Mice were infected by oral gavage of 0.1 ml of Luria-Bertani broth containing 2.5 Â 10 8 CFUs of C. rodentium. The infectious dose was verified by plating of serial dilutions on selective MacConkey plates. For survival analysis, the mice were monitored one or two times daily and moribund animals were killed with CO 2 . Mice were killed if they met any of the following clinical end points: 20% body weight loss, hunching and shaking, inactivity, ruffled fur, anal prolapse, overtly bloody stool, bleeding from the anus and body condition score o2. Enumeration of the colon and fecal bacterial load was done on different days post infection as follows: the last centimeter of the colon or feces (5 to 6 freshly collected pellets) were weighed and then homogenized in 1 ml of sterile phosphate-buffered saline using a polytron homogenizer. The polytron was cleaned extensively with 70% ethanol and water between samples. Homogenates were serially diluted (0.1 in 0.9 ml) in sterile phosphate-buffered saline and 0.1 ml aliquots of each serial dilution were plated on MacConkey agar containing chloramphenicol. C. rodentium was distinguished by its characteristic colony morphology on this medium as described previously. 12, 13, 19, 20, 23, 30 Plates containing between 30 and 300 colonies were counted. When bacterial loads were low, leading to the undiluted sample plate having o30 colonies, the number of colonies on this plate was counted. Bacterial loads were then expressed as CFU g -1 of feces or colon. The F2 mice were infected by groups of 200 mice each time. The parental strains were included as controls with every F1 and F2
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Genotyping DNA was extracted from biopsies of mouse tails with overnight digestion in lysis buffer and proteinase K, followed by a chloroform extraction. DNA concentrations were measured with Quant-iT DNA Assay Kit (Molecular Probes, Invitrogen, Burlington, ON, Canada) and adjusted to 10 ng ml -1
. Single-nucleotide polymorphisms were chosen from the Jackson Laboratories and KBiosciences (Hoddesdon, Herts, UK) collaborative mouse single-nucleotide polymorphism panel. 32 The complete list of genetic markers used in the genome scan is included in Supplementary Table 1 . Single nucleotide polymorphism genotyping was performed by KBiosciences. In-house PCRs done for mouse genotyping were sent to Genome Quebec (Montreal, QC, Canada) for sequencing with selected genetic interval markers on chr15. PCR was performed using standard touchdown PCR methods with primers obtained from the Mouse Genome Informatics website (www.informatics.jax.org).
Generation of congenic strains
To generate homozygous congenic strains, C57BL/6J were crossed to C3H/HeOuJ mice to generate (C57BL/ 6J Â C3H/HeOuJ)F1 mice, which then were backcrossed to the parental C3H/HeOuJ. The resulting N2 mice with the desired B6-derived segment of chr15 were selected by genotyping and used for subsequent backcrossing to the C3H/HeOuJ parental strain. Males and females (backcross generation N9) that inherited the intact C57BL/6J-derived congenic segment (with no detectable recombination) were intercrossed. Then, the offspring were genotyped to identify homozygotes for the desired segment, which were then intercrossed to maintain the line. Mice were housed in a pathogen-free environment.
Gross and pathology analyses Two mice from each genotype were infected by oral gavage as done for the survival analyses. At day 7 post infection, a gross/clinical examination of the animals was performed. All mice were alert and moving around normally in the cages. Body weights were measured and signs of dehydration and diarrhea were noted. The entire intestinal tract was dissected and analyzed by a pathologist.
Statistical analysis
One locus mapping for the survival phenotype for both (C57BL/6J Â C3H/HeJ) and (C57BL/6J Â C3H/HeOuJ) F2 mice was performed using a parametric survival regression at the markers under a Cox proportional hazards model for the survival time distribution. The significance was assessed via 100 000 bootstrapped resamples controlling the genome-wide type 1 error. The 1.5-LOD support intervals were obtained by interpolation on the physical map. Statistical differences between pairs of survival curves of mice grouped by genotype were calculated using log-rank tests. Statistical differences within CFU data were calculated using oneway analysis of variance followed by pairwise Dunn's post tests.
